Keyword Analysis & Research: ivabradine trial

thelancet.com

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(10)61198-1/fulltext

WEBAug 29, 2010 · SHIFT is the first trial to specifically test the effect of isolated heart-rate reduction on outcomes in a population with heart failure. … Author: Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Ler... Publish Year: 2010

Author: Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Ler...

Publish Year: 2010

DA: 38 PA: 18 MOZ Rank: 82

ahajournals.org

https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.117.004112

WEBIvabradine, a sinus node inhibitor, was shown in the SHIFT (Systolic Heart Failure Treatment With the IF Inhibitor Ivabradine Trial) trial to … Author: Debraj Das, Gianluigi Savarese, Ulf Dahlström, Michael Fu, Jonathan Howlett, Justin A. Ezekowitz, La... Publish Year: 2017

Author: Debraj Das, Gianluigi Savarese, Ulf Dahlström, Michael Fu, Jonathan Howlett, Justin A. Ezekowitz, La...

Publish Year: 2017

DA: 99 PA: 42 MOZ Rank: 67

ahajournals.org

https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.117.004112

DA: 85 PA: 80 MOZ Rank: 99

nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa1406430

WEBSep 18, 2014 · It has been shown to lessen symptoms and reduce ischemia in patients with stable angina pectoris. 7,8 Ivabradine is known to … Author: Kim Fox, Ian Ford, Ian Ford, Philippe Gabriel Steg, Jean Claude Tardif, Michal Tendera, Roberto Ferr... Publish Year: 2014

Author: Kim Fox, Ian Ford, Ian Ford, Philippe Gabriel Steg, Jean Claude Tardif, Michal Tendera, Roberto Ferr...

Publish Year: 2014

DA: 74 PA: 84 MOZ Rank: 62

nih.gov

https://pubmed.ncbi.nlm.nih.gov/20801500/

WEBSep 11, 2010 · PMID: 20801500. DOI: 10.1016/S0140-6736 (10)61198-1. Abstract. Background: Chronic heart failure is associated with high mortality and morbidity. Raised … Author: Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Ler... Publish Year: 2010

Author: Karl Swedberg, Michel Komajda, Michael Böhm, Jeffrey S Borer, Ian Ford, Ariane Dubost-Brama, Guy Ler...

Publish Year: 2010

DA: 26 PA: 70 MOZ Rank: 84

acc.org

https://www.acc.org/latest-in-cardiology/clinical-trials/2021/02/16/19/13/ivabradine-in-pots

WEBFeb 15, 2021 · The Ivabradine in POTS trial showed that ivabradine was superior to placebo at improving heart rate and quality of life among patients with hyperadrenergic …

DA: 39 PA: 37 MOZ Rank: 11

jacc.org

https://www.jacc.org/doi/10.1016/j.jacc.2017.08.038

WEBSince it was first approved for use in angina by the European Medicines Agency (EMA) in 2005, the findings of several randomized controlled trials have resulted in expanded indications to include select heart failure …

DA: 94 PA: 5 MOZ Rank: 48

tandfonline.com

https://www.tandfonline.com/doi/full/10.1080/20016689.2023.2262073

WEBOct 4, 2023 · In the SHIFT trial, treatment with ivabradine on top of background therapy compared with background therapy alone significantly reduced the risk of composite …

DA: 44 PA: 28 MOZ Rank: 71

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567656/

WEBJul 10, 2023 · In this post hoc sub‐analysis from the SHIFT trial, the effects of ivabradine on outcomes were analysed according to each of the following phenotypes: a high‐risk …

DA: 7 PA: 20 MOZ Rank: 78